Wikstrand CJ - Search Results

1

Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.

Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD. Lee YS, et al. Among authors: wikstrand cj. Cancer Res. 1988 Feb 1;48(3):559-66. Cancer Res. 1988. PMID: 2446747

2

Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.

Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD. Vrionis FD, et al. Among authors: wikstrand cj. Cancer Res. 1989 Dec 1;49(23):6645-51. Cancer Res. 1989. PMID: 2479468

3

Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.

Wikstrand CJ, McLendon RE, Bullard DE, Fredman P, Svennerholm L, Bigner DD. Wikstrand CJ, et al. Cancer Res. 1986 Nov;46(11):5933-40. Cancer Res. 1986. PMID: 3756930

4

Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration.

Lee YS, Bullard DE, Wikstrand CJ, Zalutsky MR, Muhlbaier LH, Bigner DD. Lee YS, et al. Among authors: wikstrand cj. Cancer Res. 1987 Apr 1;47(7):1941-6. Cancer Res. 1987. PMID: 3815382

5

Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Bourdon MA, et al. Among authors: wikstrand cj. Cancer Res. 1983 Jun;43(6):2796-805. Cancer Res. 1983. PMID: 6342760

6

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.

He X, Archer GE, Wikstrand CJ, Morrison SL, Zalutsky MR, Bigner DD, Batra SK. He X, et al. Among authors: wikstrand cj. J Neuroimmunol. 1994 Jul;52(2):127-37. doi: 10.1016/0165-5728(94)90106-6. J Neuroimmunol. 1994. PMID: 7518471

7

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR. Reist CJ, et al. Among authors: wikstrand cj. Cancer Res. 1995 Oct 1;55(19):4375-82. Cancer Res. 1995. PMID: 7671250

8

Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.

Wikstrand CJ, Longee DC, McLendon RE, Fuller GN, Friedman HS, Fredman P, Svennerholm L, Bigner DD. Wikstrand CJ, et al. Cancer Res. 1993 Jan 1;53(1):120-6. Cancer Res. 1993. PMID: 8416736

9

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.

Bigner DD, Brown M, Coleman RE, Friedman AH, Friedman HS, McLendon RE, Bigner SH, Zhao XG, Wikstrand CJ, Pegram CN, et al. Bigner DD, et al. Among authors: wikstrand cj. J Neurooncol. 1995;24(1):109-22. doi: 10.1007/BF01052668. J Neurooncol. 1995. PMID: 8523067 Clinical Trial.

10

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.

Reist CJ, Archer GE, Wikstrand CJ, Bigner DD, Zalutsky MR. Reist CJ, et al. Among authors: wikstrand cj. Cancer Res. 1997 Apr 15;57(8):1510-5. Cancer Res. 1997. PMID: 9108453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters